Mr Praveen Jha

Praveen Jha is a distinguished leader in the field of oncology, with a career dedicated to enhancing cancer care through precision medicine. 

At 4baseCare, he serves as the Vice President of Commercial Operations, where he spearheads initiatives aimed at making genomic testing accessible and affordable across India and other LMIC markets.

One of his notable contributions includes the launch of the LuNGS Alliance, a collaborative effort that offers free Next-Generation Sequencing (NGS) biomarker testing to lung cancer patients in India. This initiative, supported by industry leaders like AstraZeneca, Roche, and Pfizer, exemplifies his commitment to bridging the gap between cutting-edge innovation and patient access.

Praveen has also been instrumental in setting up genomic profiling labs across India, Nepal, Southeast Asia, and the Middle East—a visionary expansion strategy rooted in the belief that precision medicine should not be a privilege but a norm.

Prior to his role at 4baseCare, Praveen played a pivotal role at Foundation Medicine India, where he focused on integrating comprehensive genomic profiling into routine clinical practice. Throughout his career, he has held key positions at global pharmaceutical and healthcare companies, including Roche, Abbott, Johnson & Johnson Medical Devices, and Eli Lilly. His extensive experience encompasses marketing, strategy, and business development, with a consistent focus on improving patient outcomes through innovative healthcare solutions.